Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Non Operating Income: 2009-2024

Historic Other Non Operating Income for Ironwood Pharmaceuticals (IRWD) over the last 13 years, with Dec 2024 value amounting to $788,000.

  • Ironwood Pharmaceuticals' Other Non Operating Income was N/A to $40,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $414,000, marking a year-over-year change of. This contributed to the annual value of $788,000 for FY2024, which is 11.93% up from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Other Non Operating Income of $788,000 as of FY2024, which was up 11.93% from $704,000 recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Other Non Operating Income registered a high of $788,000 during FY2024, and its lowest value of -$290,000 during FY2022.
  • For the 3-year period, Ironwood Pharmaceuticals' Other Non Operating Income averaged around $400,667, with its median value being $704,000 (2023).
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Other Non Operating Income slumped by 168.08% in 2022 and then skyrocketed by 342.76% in 2023.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Other Non Operating Income stood at $325,000 in 2020, then spiked by 31.08% to $426,000 in 2021, then plummeted by 168.08% to -$290,000 in 2022, then skyrocketed by 342.76% to $704,000 in 2023, then grew by 11.93% to $788,000 in 2024.